Unum Group (UNM) announced that its board of directors has approved a share repurchase program authorizing the company to repurchase up to $1B ...

The Phase 1b open label clinical trial is designed to evaluate the safety and hemodynamic effect of single doses of TX45 in patients with Group 2 pulmonary hypertension. Part A is examining the effect ...